Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Spectrum Pharmaceuticals Q1 EPS $(0.02) Beats $(0.07) Estimate, Sales $15.62M Beat $10.50M Estimate; Acquisition By Assertio To Be Concluded By Q3 2023

Author: Benzinga Newsdesk | May 09, 2023 07:25am
Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.07) by 71.43 percent. This is a 77.78 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $15.62 million which beat the analyst consensus estimate of $10.50 million by 48.71 percent.

Posted In: SPPI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist